UK markets close in 6 hours 13 minutes

Hofseth BioCare ASA (0Q6H.L)

LSE - LSE Delayed price. Currency in NOK
Add to watchlist
2.1564-0.8536 (-28.36%)
As of 12:47PM BST. Market open.

Hofseth BioCare ASA

Keiser Wilhelms gate 24
Ålesund 6003
47 73 10 22 00

Full-time employees69

Key executives

NameTitlePayExercisedYear born
Mr. Jon Olav OdegardChief Executive Officer2.84MN/AN/A
Ms. Christel Elise KanliCFO & COO1.45MN/AN/A
Dr. Bomi FramrozeChief Scientific Officer9.44MN/A1961
Mr. James BergerChief Commercial Officer501kN/AN/A
Ms. Angelika FlorvaagChief Quality Officer1.26MN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in NOK.


Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States. The company's products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for VMS, metabolism, and active nutrition needs; CalGo, an absorbable complex mineral for bone and joint health; CollaGo; and PetGo, a non-soluble protein. The company was incorporated in 2000 and is headquartered in Ålesund, Norway.

Corporate governance

Hofseth BioCare ASA’s ISS governance QualityScore as of 1 July 2024 is 10. The pillar scores are Audit: 10; Board: 10; Shareholder rights: 10; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.